{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:49:13Z","timestamp":1758980953367},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2009,8,25]],"date-time":"2009-08-25T00:00:00Z","timestamp":1251158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s00296-009-1113-2","type":"journal-article","created":{"date-parts":[[2009,8,24]],"date-time":"2009-08-24T08:25:42Z","timestamp":1251102342000},"page":"1643-1645","source":"Crossref","is-referenced-by-count":9,"title":["Isoniazid-triggered pure red cell aplasia in systemic lupus erythematosus complicated with myasthenia gravis"],"prefix":"10.1007","volume":"30","author":[{"given":"Hideki","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akitomo","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Ida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Motomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Imanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,25]]},"reference":[{"key":"1113_CR1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/10245330400026154","volume":"10","author":"LC Lim","year":"2005","unstructured":"Lim LC (2005) Acquired red cell aplasia in association with the use of recombinant erythropoietin in chronic renal failure. Hematology. 10:255\u2013259","journal-title":"Hematology."},{"key":"1113_CR2","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.3748\/wjg.v13.i13.2007","volume":"13","author":"TB Liang","year":"2007","unstructured":"Liang TB, Li DL, Yu J, Bai XL, Liang L, Xu SG et al (2007) Pure red cell aplasia due to parvovirus B19 infection after liver transplantation: a case report and review of the literature. World J Gastroenterol 13:2007\u20132010","journal-title":"World J Gastroenterol"},{"key":"1113_CR3","first-page":"759","volume":"21","author":"F Atzeni","year":"2003","unstructured":"Atzeni F, Sarzi-Puttini P, Capsoni F, Vulpio L, Carrabba M (2003) Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporin A. Clin Exp Rheumatol 21:759\u2013762","journal-title":"Clin Exp Rheumatol"},{"key":"1113_CR4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1600-0609.2004.00348.x","volume":"73","author":"N Casadevall","year":"2004","unstructured":"Casadevall N, Cournoyer D, Marsh J, Messner H, Pallister C, Parker-Williams J et al (2004) Recommendations on haematological criteria for the diagnosis of epoetin-induced pure red cell aplasia. Eur J Haematol 73:389\u2013396","journal-title":"Eur J Haematol"},{"key":"1113_CR5","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.3201\/eid1309.061334","volume":"13","author":"P Loulergue","year":"2007","unstructured":"Loulergue P, Mir O, Dhote R (2007) Pure red blood cell aplasia and isoniazid use. Emerg Infect Dis 13:1427\u20131428","journal-title":"Emerg Infect Dis"},{"key":"1113_CR6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/pgmj.63.738.309","volume":"63","author":"CR Lewis","year":"1987","unstructured":"Lewis CR, Manoharan A (1987) Pure red cell hypoplasia secondary to isoniazid. Postgrad Med J 63:309\u2013310","journal-title":"Postgrad Med J"},{"key":"1113_CR7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0268-960X(96)90017-X","volume":"10","author":"AJ Erslev","year":"1996","unstructured":"Erslev AJ, Soltan A (1996) Pure red cell aplasia: a review. Blood Rev 10:20\u201328","journal-title":"Blood Rev"},{"key":"1113_CR8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V65.4.789.789","volume":"65","author":"EN Dessypris","year":"1985","unstructured":"Dessypris EN, Redline S, Harris JW, Krantz SB (1985) Diphenylhydantoin-induced pure red cell aplasia. Blood. 65:789\u2013794","journal-title":"Blood."},{"key":"1113_CR9","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/jjco\/28.11.696","volume":"28","author":"S Mizobuchi","year":"1998","unstructured":"Mizobuchi S, Yamashiro T, Nonami Y, Yamamoto A, Kume M, Nakaya H et al (1998) Pure red cell aplasia and myasthenia gravis with thymoma: a case report and review of the literature. Jpn J Clin Oncol 28:696\u2013701","journal-title":"Jpn J Clin Oncol"},{"key":"1113_CR10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1053\/sarh.2002.30440","volume":"31","author":"GS Habib","year":"2002","unstructured":"Habib GS, Saliba WR, Froom P (2002) Pure red cell aplasia and lupus. Semin Arthritis Rheum 31:279\u2013283","journal-title":"Semin Arthritis Rheum"},{"key":"1113_CR11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ajh.20237","volume":"78","author":"MO Arcasoy","year":"2005","unstructured":"Arcasoy MO, Chao NJ (2005) T-cell-mediated pure red-cell aplasia in systemic lupus erythematosus: response to cyclosporin A and mycophenolate mofetil. Am J Hematol 78:161\u2013163","journal-title":"Am J Hematol"},{"key":"1113_CR12","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3324\/haematol.11192","volume":"92","author":"K Sawada","year":"2007","unstructured":"Sawada K, Hirokawa M, Fujishima N, Teramura M, Bessho M, Dan K et al (2007) Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group. Haematologica. 92:1021\u20131028","journal-title":"Haematologica."}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-1113-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-009-1113-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-1113-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T17:34:55Z","timestamp":1590082495000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-009-1113-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,25]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["1113"],"URL":"https:\/\/doi.org\/10.1007\/s00296-009-1113-2","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,25]]}}}